Orthopedic Market

How Can Personalized, Patient-Specific Implants Become the Norm?

How Can Personalized, Patient-Specific Implants Become the Norm?

About video

Patient-specific implants and greater personalization of procedures hold exciting promise for the advancement of orthopedics. It’s generally believed that the better an implant fits a patient’s anatomy, the greater the chance for a successful outcome. This OMTEC session brought together device company, software and hospital perspectives to discuss personalized implants’ role in the future of complex and routine orthopedic surgeries.

Panelists gave 7-minute presentations on their use of patient-specific implants, and the challenges and opportunities in their work. A Q&A followed whereby the panel discussed: What changes need to occur at the design, manufacturing and supply chain levels to scale these implants? Will personalized implants become mainstream, and what market forces must they overcome to achieve prominence? How will AI and data-driven technologies change the game?

About speaker/s


Peter Verrillo, Founder and CEO, Enhatch

Peter Verrillo is the Founder and CEO of Enhatch, the Intelligent Surgery Company. Enhatch is building the future of surgery and the medical device industry, harnessing artificial intelligence to deliver a safer, faster and more accurate clinical outcome through the entire surgical experience. Before Enhatch, Mr. Verrillo launched multiple billion-dollar product lines in the orthopedic industry and also holds several seminal patents in joint arthroplasty. He graduated from Stevens Institute of Technology with a Bachelor of Engineering.

Ben Johnson 3D Systems - OMTEC Speaker

Benjamin Johnson, VP of Portfolio & Regulatory, 3D Systems

Ben Johnson’s career spans more than two decades focused on the development and commercialization of innovative medical devices. He joined 3D Systems in 2015 through the acquisition of Medical Modeling, and has held progressive roles in operations, product development, regulatory and marketing. Mr. Johnson currently serves as a leader in the Healthcare Solutions Group as the Vice President of Portfolio & Regulatory.


Joseph Lipman, Director of Device Development, HSS

Joseph Lipman is the Director of Device Development at Hospital for Special Surgery (HSS). He has over 30 years of medical research and device development experience and has worked with multiple services at HSS, including Adult Hip and Knee Replacement, Foot and Ankle, Hand and Upper Extremity, Hip Preservation, Spine and Sports Medicine. In working with these services and the Biomechanics department, he has contributed to the development of implants that have been licensed to several orthopedic companies and are sold worldwide. Mr. Lipman is a named inventor on 25 U.S. patents and has multiple publications in the medical device area.

John Slamin Conformis - OMTEC

John Slamin, CTO, Conformis

As Chief Technology Officer at Conformis, Mr. Slamin is responsible for overseeing all research and development activities related to the knee product line. He also has additional responsibility for overseeing the regulatory activities and all software development activities. Before Conformis, Mr. Slamin spent 33 years in research & development at Johnson & Johnson's Orthopaedic Division, now DePuy Synthes. Mr. Slamin is the holder of 29 patents related to orthopedic implant engineering.

OMTEC 2022 Tech Center sponsored by Lincotek Medical